Navigation Links
Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
Date:4/26/2013

EAST HANOVER, N.J., April 26, 2013 /PRNewswire/ -- Novartis Pharmaceuticals Corporation (NPC) disputes the allegations made by the US Attorney's Office (USAO) for the Southern District of New York (SDNY) in two complaints filed this week and will defend itself in these litigations. 

"We disagree with the way the government is characterizing our conduct in both of these matters and we stand behind our Compliance program," said Andre Wyss , President, Novartis Pharmaceuticals Corporation and President, Novartis Corporation . "NPC invests significant time and resources to help ensure we conduct our business in an ethical and responsible manner. We are committed to doing it right."

The first suit pertains to a previously disclosed investigation into discounts and rebates to specialty pharmacies for Myfortic®. Discounts and rebates by pharmaceutical companies are a customary, appropriate and legal practice as recognized by the Government itself. NPC believes this suit is a significant expansion of the Anti-Kickback Statute that is inconsistent with law and policy in this area, and threatens to undermine pharmaceutical company discounting practices that benefit both consumers and payers, including the Government. 

The second suit is related to a previously disclosed investigation into speaker programs conducted by NPC for the products Lotrel®, Starlix®and Valturna®. NPC believes the Government's wide-ranging allegations that its speaker programs lacked any legitimate business purpose are without merit. Physician speaker programs are promotional programs designed to inform physicians about the appropriate use of medicines and NPC has numerous controls in place to help ensure they are conducted in a compliant fashion. These progr
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novartis signs on to support Malaria No Mores Power of One campaign to stride towards a future without malaria
2. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
3. Novartis Pharma Logistics, Inc. voluntarily recalling in Jamaica select lots of certain over-the-counter products due to bottle closure defect
4. Novartis Pharma Logistics, Inc. voluntarily recalling in Trinidad & Tobago select lots of certain over-the-counter products due to bottle closure defect
5. Novartis Pharma Logistics, Inc. voluntarily recalling in Curacao select lots of certain over-the-counter products due to bottle closure defect
6. Novartis Pharma Logistics, Inc. voluntarily recalling in Aruba select lots of certain over-the-counter products due to bottle closure defect
7. Novartis Pharma Logistics, Inc. voluntarily recalling in Barbados select lots of certain over-the-counter products due to bottle closure defect
8. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
9. Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
10. Thesan Pharmaceuticals offentliggør første runde af venturefinansieringen ledt af Novo Ventures og Novartis Venture Funds i fællesskab
11. Thesan Pharmaceuticals annuncia un finanziamento di serie A co-gestito da Novo Ventures e Novartis Venture Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)... , Aug. 31, 2015  QT Vascular Ltd., together with ... together with its subsidiaries, the "Group"), a global ... of advanced therapeutic solutions for the minimally invasive ... results of the below-the-knee ("BTK") cohort of patients ... were presented on August 15, 2015 at the ...
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/wmn42n/prescription_pain ) has ... Drugs - Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ ... Opportunities: 2015 - 2020 Analysis and Forecasts" ... is defined as an unpleasant sensory and emotional ... At some point, everyone experiences pain. Pain may ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3
... Nycomed US Inc. announced today the appointment of Joseph ... General Counsel, reporting to Steve Andrzejewski, CEO of Nycomed ... the company and oversee all of the company,s legal ... be responsible for the company,s compliance functions.   ...
... RICHMOND, Va., Nov. 10, 2010 Filtrona Porous ... grade foam and fiber components designed to absorb, ... will display an expanded range of polyurethane foams ... trade fair in Dusseldorf, Germany from 17 to ...
Cached Medicine Technology:Joseph J. LaRosa Joins Nycomed US Inc. 2
(Date:8/31/2015)... ... August 31, 2015 , ... ... communications company announced today that it has officially launched a new website and ... website and brand refresh are more closely aligned with the company’s strategic vision ...
(Date:8/31/2015)... ... ... dental implant and prosthetic market in the U.S. is projected to reach $6.4 billion ... More than 30 million Americans are missing all their teeth in one or both ... National Association of Dental Laboratories (NADL) created the “What’s In Your Mouth?” campaign to ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad ... a ribbon-cutting ceremony on Aug. 26, generously hosted by the Collinsville Chamber of ... via AdvantaClean’s National Call Center and website since Aug. 17. , The Greens ...
(Date:8/31/2015)... ... ... Finnleo , a leader in the sauna industry, is pleased to announce ... re-styled and re-designed “Hallmark Series” updates the Passport series with a feature rich, portable ... and a more upscale feel than the current Passport a beautiful 6-bar two-toned curved ...
(Date:8/31/2015)... ... 31, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for its ... City. The annual legacy meeting uses a variety of formats to educate all ...
Breaking Medicine News(10 mins):Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4
... Mayo Clinic researchers have discovered two mutations responsible for ... ago. The researchers say their study -- appearing in ... neural pathway that may help understand a variety of ... now because of Next Generation genomic sequencing technology," says ...
... , SATURDAY, April 30 (HealthDay News) -- After reviewing ... up to age 3, researchers found that about 4 percent ... higher among the youngest babies, the study found. "Almost ... 2 months, received more than twice the dose that they ...
... SUNDAY, May 1 (HealthDay News) -- Increased bursts of sleep in ... new study included 23 parents who kept daily sleep records for ... at the start of the study. The researchers analyzed the total ... The infants had uneven bursts of sleep, with the amount ...
... at extremely low levels, is associated with increased blood pressure ... 1, at the Pediatric Academic Societies (PAS) annual meeting in ... increased risk of having high blood pressure, or hypertension, as ... and kidney disease and is the third leading contributor to ...
... parent or caregiver to look in the rearview mirror while ... of their safety restraints. A study on child self-unbuckling by ... first unbuckle were age three and under and that many ... a 3.5-fold increased risk for serious injuries. , "We found ...
... study in the May 1 issue of the journal Sleep ... among infants are significantly associated with growth spurts in body length. ... 24-hour sleep duration increasing at irregular intervals by an average of ... sleep episodes per day also increased in intermittent bursts of an ...
Cached Medicine News:Health News:Mayo Clinic finds new genetic cause of neurodegeneration 2Health News:Young Kids' Prescriptions Not Always on the Mark 2Health News:Extra Sleep in Infants Seems to Signal Growth Spurts 2Health News:Living with a smoker may raise blood pressure in boys 2Health News:Little fingers, big trouble: Yale study sheds light on child self-unbuckling 2Health News:Study is the first to link sleep duration to infant growth spurts 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: